A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Poland

Clinical trial NCT05384080 · COMPLETED

Trial details

NCT number: NCT05384080
Sponsor: Takeda
Status: COMPLETED
Study type: OBSERVATIONAL

Inflammatory Bowel Disease (IBD)Crohn's Disease Ulcerative Colitis

Start date: 2022-08-08
Primary completion: 2025-06-13
Enrollment: 165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.